Re: Resverlogix Announces FDA Confirmation Regarding Filing Pathway for Apabetalone
|
2
|
Resverlogix Corp.
|
Jun 15, 2018 02:20PM
|
Re: ZEN-3694 mCRPC Trial Status
|
2
|
Zenith Epigenetics
|
Oct 26, 2017 10:24AM
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
2
|
Resverlogix Corp.
|
Sep 30, 2019 09:57AM
|
Re: NR on phase 1 Kidney Trial
|
2
|
Resverlogix Corp.
|
Jan 23, 2017 02:04PM
|
Heads Up
|
2
|
Resverlogix Corp.
|
May 23, 2023 08:06PM
|
Re: What if RRR MACE is significant at 90% confidence?
|
2
|
Resverlogix Corp.
|
Apr 24, 2018 01:03PM
|
Re: ... removed posts????
|
2
|
Resverlogix Corp.
|
Oct 29, 2017 02:25PM
|
aberaterone
|
2
|
Zenith Epigenetics
|
Jun 24, 2018 01:32PM
|
Re: A comment about market penetration
|
2
|
Resverlogix Corp.
|
Mar 19, 2017 03:37PM
|
Re: Great Discussion
|
2
|
Resverlogix Corp.
|
Oct 16, 2017 05:51PM
|
Re: CANTOS and CIRT
|
2
|
Resverlogix Corp.
|
Nov 13, 2017 05:15PM
|
Re: Motley Fool - Resverlogix one of three biotechs than can "Electrify your TFSA"
|
2
|
Resverlogix Corp.
|
Jun 24, 2018 01:51PM
|
Re: Insider activity, grants of rights and an option exercise at 75 cents
|
2
|
Resverlogix Corp.
|
Jun 18, 2019 11:58AM
|
Re: Zenith Epigenetics Corp. Commences Operations
|
2
|
Zenith Epigenetics
|
Dec 09, 2015 09:50AM
|
Re: RVX ...looking bullish
|
2
|
Resverlogix Corp.
|
Aug 18, 2015 12:13PM
|
Re: Time keeps ticking
|
2
|
Resverlogix Corp.
|
Nov 18, 2021 06:43PM
|
Re: Zenith funding???
|
2
|
Zenith Epigenetics
|
Jun 18, 2019 12:19PM
|
Re: BIO Investor Forum, Oct 22-23
|
2
|
Zenith Epigenetics
|
Oct 24, 2019 04:18PM
|
Re: Calgary-developed COVID-19 drug begins trials in local hospitals and Brazil.
|
2
|
Resverlogix Corp.
|
Feb 20, 2022 06:26PM
|
Re: if a Pharma offered $4-$5/shr
|
2
|
Resverlogix Corp.
|
Oct 01, 2019 01:08PM
|